ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Recruiting
Observational Study
NSCLC Stage IV
Sex Disorder
Hypogonadism, Male
Erectile Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Male
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Although many phase III clinical trials evaluate the quality of life as a secondary endpoint, male sexuality remains a neglected topic in oncology research. In light of the long-term efficacy of new-generation anticancer treatments for ANSCLC (i.e. targeted therapies and immunotherapy), there is a paucity of data about any detrimental effect on fertility and sexuality that could complicate the the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of advanced/metastatic NSCLC
* To be candidate to active treatment
* Aged ≥ 18 anni (up to 75 years old)
* To be sexually active in last 30 days before treatment start
* Eastern Cooperative Oncology Group (ECOG) performance status 0-1
* Written informed consent
Excl…
Contacts